rs72554310
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_000531.6(OTC):c.131C>T(p.Thr44Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. T44T) has been classified as Likely benign.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.131C>T | p.Thr44Ile | missense_variant | Exon 2 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.131C>T | p.Thr44Ile | missense_variant | Exon 4 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.131C>T | p.Thr44Ile | missense_variant | Exon 2 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
The c.131C>T;p.(Thr44Ile) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (Clinvar ID:97109; PMID: 8830175; 17041896; 25994866) - PS4. Well-established in vitro or in vivo functional studies support a damaging effect on the gene or gene product (PMID: 17041896) - PS3_supporting. This variant is not present in population databases (rs72554310, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. The variant was assumed de novo, but without confirmation of paternity and maternity (PMID:8830175) - PM6. Missense variant in OTC that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease - PP2. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. Patient’s phenotype is highly specific for a disease with a single genetic etiology - PP4. In summary, the currently available evidence indicates that the variant is pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at